Journal of Cancer Research and Therapeutics Close
 

Figure 1: Effects of anti-ABCC3 IgG-positive plasma on the proliferation of oral squamous cell carcinoma cell lines compared with IgG-negative plasma. CAL27 cells (a) and SCC15 cells (b) were treated with anti-ABCC3 IgG-positive plasma for 48 h. Plasma A and plasma B were obtained from two healthy donors, respectively. The data were expressed as mean ± standard deviation in cell viability; NS: Not significant

Figure 1: Effects of anti-ABCC3 IgG-positive plasma on the proliferation of oral squamous cell carcinoma cell lines compared with IgG-negative plasma. CAL27 cells (a) and SCC15 cells (b) were treated with anti-ABCC3 IgG-positive plasma for 48 h. Plasma A and plasma B were obtained from two healthy donors, respectively. The data were expressed as mean ± standard deviation in cell viability; NS: Not significant